🇺🇸 FDA
Pipeline program

TEV-53408, Placebo to match TEV-53408

TV53408-IMM-20042

Phase 2 small_molecule active

Quick answer

TEV-53408, Placebo to match TEV-53408 for Celiac Disease is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Celiac Disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials